Effects of Bone Marrow Mononuclear Cell Implantation Induced by 5-Azacytidine on Cardiac Function

徐红新,李庚山,江洪,吕菁君,钱海燕,王晶
DOI: https://doi.org/10.3760/cma.j.issn.1001-4497.2004.02.013
2004-01-01
Abstract:Objective: Recent studies have shown that cell implantation can replace infarcted myocardium to improve cardiac performance. The present study was designed to investigate the effects of autologous bone marrow mononuclear cell (BM-MNC) implantation into myocardium bordering the infarction with or without induced by 5-azacytidine on cardiac function after acute myocardial infarction (AMI) in rabbits. Methods: AMI was replicated by ligating the left anterior descending coronary artery. Rabbits were randomly divided into three groups: (1) BM -MNC induced by 5-azacytidine implantation (n=7), (2) BM-MNC implantation alo ne (n=7), and (3) AMI control (n=7). In addition, sham-operated (n=5) rabbit s were randomly selected to serve as non-infarction control. Animals for cell im p lantation were received intramyocardial injection of autologous BM-MNC in myoca rdium bordering the infarction, and echocardiography and hemodynamic studies wer e performed to evaluate cardiac function following 28 days of implantation. Results: Compared with the sham-operated group, the left ventricle (LV) end diastolic pressure (LVEDP) was significantly increased (P0.05) in all AMI procedure groups. The ΔD (Dd minus Ds) to Dd ratio (ΔD/Dd), wall thickness, ejection fraction (EF), left ventricle systolic pressure (LVSP) and maximum LV pressure rising rates (dp/dtmax) were all significantly reduced (all P 0.05). These changes indicated LV remodeling occurred and LV function were impaired. Comparison among all AMI procedure groups showed that impaired LV function were improved by autologous BM-MNC implantation, as revealed by decreased LVEDP (BM-MNC implantation vs. AMI alone, P0.05) and increased ΔD/Dd, wall thickness, EF, LVSP, and dp/dt max (BM-MNC implantation vs. AMI alone, all P0.05). Furthermore, BM-MNC induced by 5-azacytidine implantation did not confer a further improvement of cardiac function with non-significant changes of all assessed parameters when compared with BM-MNC implantation alone (all P0.05). Conclusion: BM-MNC induced by 5-azacytidine implantation into myocardium bordering the infarction can significantly improve impaired cardiac function associated with LV remodeling after AMI, however such improvement is not further promoted compared with that in BM-MNC implantation group alone.
What problem does this paper attempt to address?